Tag Archives: Pharmaceutical Litigation

VIOXX® Class Action Suits Suffer Setback in California Courts

In a statement released on Pharmaceutical Online, Los Angeles Superior Court Judge Victoria Chaney struck down a request to certify a class of consumers and insurers seeking reimbursement from drug manufacturer Merck over costs of VIOXX®. The ruling dashes the hopes of plaintiffs and insurance companies who sought the ability to conduct class-action suits seeking compensation for the pain medication’s tendency to increase the risk of heart attacks or...
Read More

FDA Recalls Hydroxycut

The United States Food and Drug Administration (FDA) has officially warned consumers to discontinue using the popular weight loss product, Hydroxycut. In a press release issued May 1, 2009, the FDA made the warning about the product after receiving numerous reports of serious liver damage among those using the dietary supplement products. As of the time of the recall announcement, Hydroxycut has been involved in at least one death...
Read More